Integra LifeSciences Holdings Corporation (IART) Insider Trading Activity

NASDAQ$17.51
Market Cap
$1.36B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
311 of 870
Rank in Industry
48 of 112

IART Insider Trading Activity

IART Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$102,150
1
100
Sells
$0
0
0

Related Transactions

GRAVES JEFFREY Adirector
1
$102,150
0
$0
$102,150

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

Insider Activity of Integra LifeSciences Holdings Corporation

Over the last 12 months, insiders at Integra LifeSciences Holdings Corporation have bought $102,150 and sold $0 worth of Integra LifeSciences Holdings Corporation stock.

On average, over the past 5 years, insiders at Integra LifeSciences Holdings Corporation have bought $999,322 and sold $12.62M worth of stock each year.

Highest buying activity among insiders over the last 12 months: GRAVES JEFFREY A (director) — $102,150.

The last purchase of 9,000 shares for transaction amount of $102,150 was made by GRAVES JEFFREY A (director) on 2025‑11‑05.

List of Insider Buy and Sell Transactions, Integra LifeSciences Holdings Corporation

2025-11-05PurchaseGRAVES JEFFREY Adirector
9,000
0.0109%
$11.35
$102,150
+5.35%
2024-12-03SaleSchwartz EricEVP, Chief Legal Officer & Sec
4,070
0.0053%
$24.59
$100,102
-39.71%
2024-12-02SaleMcBreen Michael J.EVP & President, CSS
1,700
0.0022%
$24.16
$41,064
-39.52%
2024-08-19SaleMosebrook JeffreySVP, Fin & Princ Acct Officer
1,191
0.0015%
$21.58
$25,701
-10.58%
2024-05-23PurchaseESSIG STUARTExec. Chairman of the Board
52,641
0.0668%
$28.49
$1.5M
-21.66%
2024-05-21PurchaseHILL BARBARA Bdirector
36,350
0.0462%
$27.40
$995,816
-18.24%
2024-03-06SaleDAVIS ROBERT T. JR.EVP & President, TT
8,348
0.0109%
$36.59
$305,492
-31.89%
2023-08-09SaleMosebrook JeffreySVP, Fin & PAO
1,177
0.0014%
$44.46
$52,329
-14.98%
2023-06-01PurchaseSchwartz EricEVP, Chief Legal Officer & Sec
2,640
0.0032%
$37.89
$100,035
+2.94%
2023-06-01PurchaseDe Witte JanPresident & CEO
7,792
0.0095%
$38.50
$299,986
+2.94%
2023-03-07SaleMcBreen Michael J.EVP & President, CSS
1,843
0.0023%
$54.29
$100,064
-22.82%
2023-03-01SaleDAVIS ROBERT T. JR.EVP & President, TT
1,566
0.0019%
$55.21
$86,463
-23.10%
2023-02-27SaleEvoli LisaEVP & CHRO
3,767
0.0046%
$57.00
$214,731
-25.87%
2022-12-08SaleMosebrook JeffreySVP, Fin & Princ Acct Officer
279
0.0003%
$56.22
$15,684
-21.17%
2022-08-10SaleEvoli LisaExecutive Vice President &CHRO
1,165
0.0014%
$55.81
$65,020
-7.17%
2022-08-05SaleMurphy Raymond G.
8,000
0.0096%
$55.78
$446,266
-5.84%
2022-08-02SaleMosebrook JeffreySVP, Fin & Princ Acct Officer
437
0.0005%
$56.77
$24,811
-5.40%
2022-06-15SaleEvoli LisaExecutive Vice President &CHRO
900
0.0011%
$55.93
$50,337
-3.92%
2022-05-24SaleEvoli LisaExecutive Vice President &CHRO
250
0.0003%
$59.85
$14,963
-8.85%
2022-04-04SaleColeman GlennExecutive Vice President & COO
6,268
0.0077%
$66.04
$413,939
-14.16%
Total: 400
*Gray background shows transactions not older than one year

Insider Historical Profitability

3.4%
GRAVES JEFFREY Adirector
41086
0.0528%
$719,415.8610
CARUSO RICHARD E10 percent owner
10291205
13.2283%
$180.2M112
+23.04%
Tru St Partnership, L.P.10 percent owner
8515930
10.9464%
$149.11M09
SOROS GEORGE10 percent owner
2725300
3.5031%
$47.72M017
ESSIG STUARTExec. Chairman of the Board
487922
0.6272%
$8.54M174
<0.0001%
Arduini Peter JPresident & CEO
216713
0.2786%
$3.79M014
SULLIVAN JAMES Mdirector
59604
0.0766%
$1.04M08
Schwartz EricEVP, Chief Legal Officer & Sec
59511
0.0765%
$1.04M14
+2.94%
McBreen Michael J.EVP & President, CSS
56182
0.0722%
$983,746.8206
DAVIS ROBERT T. JR.EVP & President, TT
49893
0.0641%
$873,626.4305
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
42473
0.0546%
$743,702.2307
Coleman GlennExecutive Vice President & COO
41288
0.0531%
$722,952.88016
Murphy Raymond G.
40825
0.0525%
$714,845.7507
MOREL DONALD E JRdirector
37112
0.0477%
$649,831.1220
+6.47%
BRADLEY KEITHdirector
37065
0.0476%
$649,008.1508
HILL BARBARA Bdirector
36350
0.0467%
$636,488.5040
+3.52%
Mosebrook JeffreySVP, Fin & Princ Acct Officer
36088
0.0464%
$631,900.88010
HENNEMAN JOHN B IIICorpVP, CAO
34159
0.0439%
$598,124.09054
PALTRIDGE ROBERT DCorp VP, Pres. Extrem Recon
33590
0.0432%
$588,160.9004
SCHADE CHRISTIAN Sdirector
32633
0.0419%
$571,403.8304
GORELICK RICHARD D.Corp VP, Gen Counsel & Sec
21565
0.0277%
$377,603.1506
NOCIOLO DON RSenior VP, Operations
18984
0.0244%
$332,409.8407
Evoli LisaEVP & CHRO
18605
0.0239%
$325,773.55012
MOORADIAN JOHNCorp VP, Global Ops & Supp Chn
15410
0.0198%
$269,829.1005
De Witte JanPresident & CEO
12798
0.0165%
$224,092.9810
+2.94%
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
12465
0.016%
$218,262.1501
HOLTZ DAVID BSenior VP, Finance (1)
10248
0.0132%
$179,442.4806
LEONETTI DEBORAH ACorp VP, Glbl Servs & Repair
8715
0.0112%
$152,599.65011
Corbin Jerry ECorp VP & Corporate Controller
8677
0.0112%
$151,934.2704
VINHAIS JOSEPHCorp VP,Quality&Transformation
8231
0.0106%
$144,124.8104
CARLOZZI GERARD SExecutive Vice President & COO
7813
0.01%
$136,805.63021
OGRADY JUDITHCorpVP,Reg.Affairs,CorpCompli
7206
0.0093%
$126,177.06041
LARKIN BRIANCorp VP, Pres.Gbl Spine &Ortho
7069
0.0091%
$123,778.1904
Ballintyn Rhonda Germanydirector
3665
0.0047%
$64,174.1510
+3.09%
MOSZKOWSKI NEALdirector
3511
0.0045%
$61,477.6102
VANLENT ANNEdirector
3478
0.0045%
$60,899.7801
PIERSHBACHER MICHAELSenior V.P.., R&D
0
0%
$004
*Gray background shows insiders who have made transactions during last year

IART Institutional Investors: Active Positions

Increased Positions108+45.19%8M+10.73%
Decreased Positions106-44.35%5M-6.68%
New Positions36New3MNew
Sold Out Positions33Sold Out2MSold Out
Total Postitions241+0.84%76M+4.06%

IART Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$122,852.0013.11%10.23M-122,569-1.18%2025-09-30
Rubric Capital Management Lp$91,924.009.81%7.65M+300,000+4.08%2025-09-30
Vanguard Group Inc$88,623.009.46%7.38M-199,166-2.63%2025-09-30
Fuller & Thaler Asset Management, Inc.$47,012.005.02%3.91M+21,906+0.56%2025-09-30
Morgan Stanley$45,934.004.9%3.82M-109,347-2.78%2025-09-30
Invesco Ltd.$41,926.004.48%3.49M-46,299-1.31%2025-09-30
Dimensional Fund Advisors Lp$38,249.004.08%3.18M+267,134+9.16%2025-09-30
State Street Corp$33,519.003.58%2.79M-35,567-1.26%2025-09-30
Paradigm Capital Management Inc/Ny$30,383.003.24%2.53M+348,300+15.97%2025-09-30
Geode Capital Management, Llc$18,594.001.99%1.55M-94,331-5.74%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.